Medigene AG: Notification § 27a

Issuer information:

Name: Medigene AG
Addresse: Lochhamer Str. 11, 82152 Planegg/Martinsried
Location: Martinsried
Country: Germany
Security Code Number: A1X3W0 / A161NA
ISIN: DE000A1X3W00 / ISIN DE000A161NA3

On 22 July 2015, Aviva plc informed us in accordance with Section 27a, para.1, sentence 3 German Securities Trading Act (Wertpapierhandelsgesetz - WpHG), that Aviva plc has exceeded a 10% holding threshold in Medigene AG.

Aviva plc confirmed the following:

1.         The investment is not aimed to implement strategic objectives but is aimed at generating a trading profit.

2.         There are no plans to acquire further voting rights within the next twelve months by means of a purchase or by any other means.

3.         It is not our objective to nominate onto or remove directors from the Board, but if we feel there are issues with board composition we would, in our engagement with the company encourage it to address any concerns we may have. We expect boards to be effective in safeguarding shareholder interests and they should have the right skills and experience to take the company's strategy forward. In particular we recognise the important (and independent) role of the chairman and non-executive directors in providing appropriate internal challenge to board discussions and decisions to ensure that all directors act in the best interests of the company. We also place particular importance on boards setting appropriate standards and values for the company both in terms of corporate responsibility and also on doing the right thing in the way companies make decisions.